Press Release: WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS

Dow Jones
04-26

WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS

PR Newswire

SUNNYVALE, Calif., April 25, 2025

SUNNYVALE, Calif., April 25, 2025 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general and special meeting of shareholders held on April 25, 2025 (the "Meeting"). A total of 59,214,893 common shares, representing approximately 40.88% of the Company's issued and outstanding shares were represented at the meeting.

The shareholders approved the setting of the number of directors of Willow at 5 directors, and the following nominees were elected as directors of Willow for the ensuing year with the specific voting results being as follows:

 
                       Votes For        Votes Withheld 
-----------------  ------------------  ----------------- 
Director               #         %         #        % 
-----------------  ----------  ------  ---------  ------ 
Dr. Chris Savile   46,902,346  88.3 %  6,234,676  11.7 % 
-----------------  ----------  ------  ---------  ------ 
Dr. Jim Lalonde    46,965,380  88.4 %  6,171,642  11.6 % 
-----------------  ----------  ------  ---------  ------ 
Donald Archibald   44,900,287  84.5 %  8,236,735  15.5 % 
-----------------  ----------  ------  ---------  ------ 
Raffi Asadorian    46,963,057  88.4 %  6,173,965  11.6 % 
-----------------  ----------  ------  ---------  ------ 
Al Foreman         46,900,723  88.3 %  6,236,299  11.7 % 
-----------------  ----------  ------  ---------  ------ 
 

In addition, shareholders approved the below matters. The resolutions approving the below matters may be viewed in full in the Company's management information circular dated March 26, 2025 (the "Information Circular").

 
                                                                Votes For 
----------------------------------------------------------  ------------------ 
Director                                                        #         % 
----------------------------------------------------------  ----------  ------ 
Appointment of KPMG LLP as the Company's auditor for the 
 ensuring year                                              51,882,364  87.6 % 
----------------------------------------------------------  ----------  ------ 
The proposed sale of the shares of Epimeron USA, Inc., the 
 Corporation's wholly-owned subsidiary, as more 
 particularly described in the Information Circular         46,996,397  88.4 % 
----------------------------------------------------------  ----------  ------ 
To authorize the Corporation's board of directors, at its 
 sole discretion, to amend the Articles of the Corporation 
 to change its name from "Willow Biosciences Inc." to 
 "2482118 Alberta Ltd.", or such other name as may be 
 approved by the Board, as more particularly described in 
 the Information Circular.                                  48,853,362  82.5 % 
----------------------------------------------------------  ----------  ------ 
 

For complete voting results on all matters approved at the Meeting, please see the Company's Report of Voting Results dated April 25, 2025, available on SEDAR+ at www.sedarplus.ca.

About Willow Biosciences Inc.

Willow develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow's FutureGrown$(TM)$ biotechnology platform allows large-scale production with sustainability at its core. Willow's R&D team has a proven track record of developing and commercializing bio-based manufacturing processes and products to benefit our B2B partners and their customers.

For more information, visit www.willowbio.com or contact:

Travis Doupe

Chief Financial Officer

E: info@willowbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/willow-biosciences-announces-annual-general-and-special-meeting-voting-results-302438831.html

SOURCE Willow Biosciences Inc.

 

(END) Dow Jones Newswires

April 25, 2025 19:22 ET (23:22 GMT)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10